Kenneth Waggoner, outgoing PharmaCyte CEO
Under the weight of a 2-year clinical hold, a biotech’s new board starts company review, ousts CEO
After nearly 10 years steering the ship at PharmaCyte Biotech, Kenneth Waggoner is out the door of the biotech, as of yesterday, and the former …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
